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ABSTRACT
Background and aims: Upper gastrointestinal adeno-
carcinomas show an unexplained male predominance that
is more apparent in oesophagus than stomach and in
intestinal than diffuse histological subtype. We have
conducted a population-based study to determine
whether the gender phenomenon is primarily related to
the anatomical site or the histological subtype.
Method and materials: Of 3270 gastric and oesopha-
geal cancers recorded in the West of Scotland Cancer
Registry, 1998–2002, 812 were randomly selected for
detailed analysis. The Lauren histological subtype of
adenocarcinoma was determined by reviewing 1204
original reports and 3241 biopsies.
Results: Analysis included 405 non-cardia cancers, 173
cardia cancers and 209 oesophageal adenocarcinomas.
Crude incidence rate of intestinal subtype was higher in
males (23.86/100 000 person-years) versus females
(9.00/100 000 person-years), giving a male/female (M/F)
ratio of 2.65 whereas diffuse subtype was similar for both
genders (5.58 vs 5.20/100 000 person-years) yielding M/
F of 1.07. The M/F ratios for oesophageal, cardia and non-
cardia gastric cancer were 3.5, 2.0 and 1.6, respectively.
Multiple logistic regression indicated that the odds of
male gender was related to the histological subtype rather
than anatomical location (odds ratio 2.6, 95% confidence
interval 1.78 to 3.9). Curve fitting of the age-specific
incidence of intestinal subtype indicated that similar
functions describe the rise in incidence with age in males
and in females. However, the age-specific incidence of
female intestinal subtype was delayed by 17.3 years. The
M/F ratio of intestinal subtype was 3.41 at age
,50 years, peaked at 7.86 at age 50–59 years and then
showed a progressive decrease after 50–60 years of age.
Conclusion: Male predominance of upper gastrointest-
inal adenocarcinoma is related to the intestinal histological
subtype rather than tumour location and is due to marked
delayed development of this subtype in females prior to
50–60 years of age.
A remarkable and unexplained characteristic of
upper gastrointestinal adenocarcinoma is its male
predominance. This male predominance of gastric
cancer is related to the histological subtype of the
tumour. Gastric adenocarcinoma may be of the
intestinal or diffuse histological subtype as
described by Lauren.1 The intestinal subtype is
strongly linked to chronic Helicobacter pylori super-
ficial gastritis. According to Correa et al,2 the latter
may induce intestinal metaplasia of the gastric
mucosa from which the intestinal subtype cancer
is thought to develop. The diffuse histological
subtype of gastric cancer is less strongly associated
with H pylori infection and genetic predisposition is
thought to be more important.3–5 The gender
phenomenon is more marked in gastric cancer of
the intestinal versus diffuse histological subtype
and this has been described well by Sipponen and
colleagues.6 However, few, if any, cancer registries
have reliable records of the histological subtype of
gastric and oesophageal cancer and therefore true
population-based incidence studies of the influence
of gender on intestinal versus diffuse gastric cancer
are lacking.
Interest in the role of gender in upper gastro-
intestinal cancer has been rekindled by the rapidly
rising incidence of adenocarcinoma of the oeso-
phagus in the Western world.7 These cancers also
demonstrate a marked male predominance and
tend to present at a younger age in males.8
Adenocarcinoma of the oesophagus is considered
to be a consequence of chronic damage to the
squamous mucosa of the distal oesophagus by acid,
pepsin and probably bile refluxing from the
stomach and small intestine.9 10 In response to this
chronic damage, the oesophageal squamous epithe-
lium undergoes metaplasia to become columnar in
type and eventually resembling that of the small or
large intestine.11 12 Oesophageal adenocarcinoma is
thought to arise from this intestinal metaplasia
and histologically resembles the intestinal subtype
of gastric adenocarcinoma.
Global data from cancer registries suggest that
the male predominance of upper gastrointestinal
cancer is related to the anatomical location, being
higher for adenocarcinoma of the oesophagus and
lower for adenocarcinoma of the distal stomach.13
The male-to-female ratio of age-standardised inci-
dence rates for oesophageal adenocarcinoma in
Scotland is of the order of 4.5:1, for adenocarci-
noma of the proximal cardia region of the stomach
or gastro-oesophageal junction it is 3.5:1 and for
more distal gastric cancer it is 2.0:1.14 However, the
proportion of the intestinal histological subtype
differs according to anatomical site and it is unclear
whether it is the anatomical site or the histological
subtype which is associated with the gender
phenomenon.
Understanding the point at which the gender
phenomenon is acting will facilitate unravelling its
mechanism. We have therefore conducted a popu-
lation-based study to determine whether the
gender phenomenon is primarily related to the
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anatomical site or to the histological subtype of adenocarci-
noma of the upper gastrointestinal tract. This has been
conducted in the west of Scotland, a region with a moderately
high incidence of gastric cancer and with the highest recorded
incidence of oesophageal adenocarcinoma in the world.14 Our
findings indicate that the intestinal subtype has the greatest
impact on the gender ratio and this is unrelated to whether the
carcinoma has developed in the oesophagus or distal stomach.
Our study also indicates that the gender phenomenon is due to
the development of the intestinal subtype of cancer being
delayed by 17.3 years in females.
METHODS AND MATERIALS
The study was based on patients with a diagnosis of gastric or
oesophageal cancer recorded in the West of Scotland Cancer
Registry between 1998 and 2002. The Cancer Registry covered
more than half the Scottish population at this time. The registry
constantly monitors data quality to evaluate reliability of
recorded diagnosis. According to a recent reliability report in
1997, there was a 97% agreement in coding the major tumour
site category based on ICD-10 and only 2% discrepancy in
microscopic verifications of tumours.15 Registration of cancers
based on ‘‘death certificate only’’ criteria for all malignant
neoplasma, excluding non-melanoma skin cancer was only 0.4%
in 1997.15 For the time period included in our study, the
estimated completeness of cancer registration was .96%.16
Selection process
We collected the tumour identification number of all cases of
gastric and oesophageal adenocarcinoma recorded in the west of
Scotland during the 5 year period 1998–2002. The study was
conducted on histology slides and records of 812 randomly
selected patients from a total of 3270 cases of gastric and
oesophageal cancers recorded in the database. The number of
samples was stratified by tumour site to ensure that the sites are
present in the sample in the same proportion as in the
population. A random sample of pre-defined size was selected
from each group of cancers (approximately 25% for each site).
Randomisation was performed with a computerised random
number generator (SPSS, Chicago, Illinois, USA). To be included
in the study, all cases were required to have histological samples
available for microscopic verification.
Histological study
All pathology records of sampled subjects were reviewed for
microscopic diagnosis and anatomical site of tumour using ICD-
10 and ICD O-2. The histological subtype of adenocarcinoma
was determined by the Lauren classification.1 When the
information on the pathology reports was inadequate, the
original microscopy slides were re-evaluated by the study
pathologists using the Lauren classification. In order to ensure
compatibility of reported classifications with our study defini-
tions, at least 10% of all specimens with complete histology
records were selected randomly for re-examination using the
same protocol.
Statistical analysis
Binary logistic regression models were used to estimate the
relationship between the odds of male gender (dependent
variable) and histological subtype, tumour location and age
(independent variables). The histological subtype included
intestinal and diffuse subtypes but not mixed subgroup due to
a very small percentage of this type in the population sample.
All gastric and oesophageal tumours of histology other than
adenocarcinoma were excluded from analysis. Tumour location
was defined as oesophageal, gastric cardia and gastric non-cardia
as defined in the cancer registry database. Patients were
categorised into five age groups: ,50, 50–59, 60–69, 70–79 and
>80. The 10 year groupings were arbitrarily chosen on
common-sense grounds; the top and bottom groups extend
beyond a decade to ensure all groups have an adequate number
of patients. Grouping age in this way for the logistic regression
means that no assumptions have to be made about the form of
the relationship (eg, linear) between age and the odds of male
gender. The logistic regression models were used to estimate the
odds of male gender for the categories of the independent
variables, the associated 95% confidence intervals and the
associated p values. Logistic regression models were fitted
initially for each independent variable separately. A multiple
logistic regression model was finally fitted including all the
independent variables. All two-way interactions between the
independent variables were initially considered in this multi-
variable model, but as none were statistically significant at 10%
they were omitted from the final analysis.
Supplementary studies
As the above analysis indicated that male predominance was
associated with the intestinal histological subtype and not
tumour location, we proceeded to investigate characteristics of
the male predominance affecting the intestinal versus diffuse
subtype of tumours. This included modelling the age specific
incidence in males versus females in the intestinal and diffuse
tumours and also of other tumours in our cancer registry.
Curve fitting age-specific cancer incidence data
A curve fitting approach was taken to quantitatively describe
the age-specific incidence of cancer using non-linear regression
analysis. The equation I(t) = a6(t2d)b was fitted to the age-
specific incidence data using the SOLVER function of Excel.17 In
this equation, It is the age-specific incidence of cancer (per
100 000 person-year) at age t (the mean age of the group); and a,
b and d are regression constants, where a is a scaling factor, b is a
power term that reflects the rate of incidence with age and d is a
delay term for the time between birth and age of increased
incidence above zero. A logic IF function was used in Excel such
that when t,d (t2d,0), I(t) = 0. Thus only when d.t was
I(t).0.
The difference between the data and the model (sum of the
square differences (SS)) was computed and the target function
which was minimismed by non-linear regression analysis using
generalised reduced gradient (GRG2) non-linear optimisation
was the root mean square of SS. Curve fits were obtained using
similar starting estimates for all age-specific incidence data.
Comparison of gender related, age-specific incidence with other
cancers
The 1998–2002 average age-group-specific incidence (per
100 000 person-years) were extracted from the ISD Scottish
Cancer Registry for cancer of the oesophagus, adenocarcinoma
(ICD-10: C15, ICD-O-2 various); cancer of the oesophagus,
squamous cell (ICD-10: C15, ICD-O-2 8050-8076); cancer of the
lung, squamous cell carcinoma (ICD-10: C33-34; ICD-O-2:
8050–8076), cancer of the lung, adenocarcinoma (ICD-10: C33-
34; ICD-O-2: various); cancer of the lung, small cell carcinoma
(ICD-10: C33-34; ICD-O-2: 8040–8045); cancer of the bladder,
squamous cell carcinoma (ICD-10: C67; ICD-O-2: 8051–8076);
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cancer of the bladder, transitional cell carcinoma (ICD-10: C67;
ICD–O-2: 8050, 8120–8122, 8130); cancer of the colon (ICD-10:
C18; ICD-O-2: various); and cancer of the pancreas (ICD-10:
C25; ICD-O-2: various). These cancers were recorded for the
West of Scotland Cancer Registry matching the population for
gastric and oesophageal cancer. The age-specific incidence of
these cancers were also analysed by curve fitting, as described
previously, to examine gender differences in the incidence rate
and the age at which incidence increased above zero.
RESULTS
In total 812 incident cancers with histological diagnosis of
oesophageal adenocarcinoma (C15), gastric cardia cancer
(C16.0) and gastric non-cardia cancer (C16.1–16.9) were
reviewed. Of these, 25 records (3.1%) were excluded because
both original reports and materials were missing (n = 9) or they
were recorded in duplicate (n = 16). After the first round of
document review, 3241 slides from 463 cancer cases were
reviewed because their original records had inadequate informa-
tion regarding the Lauren histological subtypes. Among 349
reports with adequate information, 42 reports were selected
randomly and related slides were re-evaluated. Classification of
only two cases (,5%) required to be changed (from diffuse
subtype to mixed subtype). The distribution of cancers by sex
and anatomical site in the sample studied showed no statistical
difference from the correspondent entire cancer registry data.
Regardless of anatomical subsite, the upper gastrointestinal
(GI) cancers were more common in males (502, 63.8%) than
females (285, 36.2%). Four hundred and five (51.5%) of the
cancers originated from the non-cardia region of the stomach,
173 (22.0%) from the gastric cardia and 209 (26.6%) from the
oesophagus.
Histologically, 63.8% of all tumours were of intestinal and
21.3% of diffuse subtype (table 1). Of the remaining 117, 25.6%
were mixed type of Lauren classification, 30.8% undifferentiated
carcinoma, and 43.6% of other histological diagnosis. The last
group included adenosquamous carcinoma (n = 1), large cell
carcinoma (n = 1), leiomyosarcoma (n = 1), lymphoma (n = 1),
carcinoid tumour (n = 7), carcinoma in situ (n = 7), squamous
cell carcinoma (n = 10) and metastatic tumours of unknown
origin (n = 23). For the purpose of this study, we only analysed
the data of patients with either intestinal or diffuse type
carcinoma which included more than 85% of incident cancers.
The proportion of histological subtypes varied with tumour
location. Intestinal/diffuse subtype ratio was 163/17 (9.6: 1) for
oesophageal adenocarcinomas, 102/32 (3.2: 1) for cardia and
227/119 (1.9: 1) for non-cardia adenocarcinomas.
Association of male predominance with tumour location vs
histological subtype
Gender and histological subtypes
Regardless of anatomical site, the crude incidence rate of
intestinal subtype upper GI adenocarcinoma was higher in
males, at 23.86 per 100 000 person-years, versus females, at 9.00
per 100 000 person-years, resulting in an M/F ratio of 2.65. In
contrast, the crude incidence rate of diffuse subtype adenocar-
cinoma was similar in males and females (5.58 vs 5.20 per
100 000 person-years) yielding an M/F ratio of 1.07 (table 2 and
fig 1). The gender effect expressed as M/F incidence ratio varied
with age and histological subtype. As shown in fig 2, the M/F
ratio of intestinal subtype cancer was 3.41 at age less than 50,
reached a peak of 7.86 at age 50–59 years, and then showed a
progressive decrease with a minimum of 2.29 at age group
80 years and over. In contrast, M/F ratio of diffuse subtype
cancer was 0.89 at age less than 50 and did not show any
significant changes with increasing age.
Gender and tumour location
Regardless of histological subtype, the male predominance of
adenocarcinoma incidence varied with anatomical location
(table 3). Male predominance was greatest in the oesophagus
with crude incidence rates of 9.21 and 2.63 in males versus
females, respectively (M/F = 3.50). For cardia cancer the crude
incidence rates were 6.25 and 3.12 for males and females,
respectively (M/F = 2.00), and for non-cardia cancer 13.98 and
8.46 (M/F = 1.65).
Multivariable analysis of male predominance risk factors
Multivariable logistic regression including histological subtype,
tumour location and age indicated that the odds of male
gender was mainly related to the histological subtype and age
rather than anatomical location. Although the odds of male
gender was higher for oesophageal versus non-cardia adeno-
carcinoma when anatomical location was considered alone in
a logistic regression model (odds ratio (OR) 2.11, 95%
confidence interval (CI) 1.41 to 3.17), this relationship with
anatomical location lost statistical significance in the multi-
variable analysis when histological subtype and age were
added (OR = 1.37, 95% CI 0.88 to 2.12). In addition, the
overall significance level in the logistic regression model for
anatomical location diminished from p,0.001 when it was
considered alone to p = 0.333 when considered together with
age and histological subtype. This suggests that male
predominance in upper GI adenocarcinomas was not primarily
a function of tumour location but rather related to
histological subtype and age (table 4). Intestinal subtype
Table 1 Crude incidence rates of upper gastrointestinal cancer of the random sample from the West of Scotland by histology and tumour location
Histology
Tumour location
Gastric non-cardia Gastric cardia Oesophageal adenocarcinoma
Number Incidence rate* Number Incidence rate* Number Incidence rate*
M F M F M F M F M F M F
Intestinal 151 76 10.14 4.66 76 36 5.10 2.20 128 35 8.60 2.14
Diffuse 57 62 3.82 3.79 17 15 1.14 0.91 9 8 0.60 0.49
Mixed 9 6 0.60 0.37 4 3 0.27 0.18 6 2 0.40 0.12
Undifferentiated 7 8 0.47 0.49 6 4 0.40 0.24 9 2 0.60 0.12
Other 10 19 0.67 1.16 5 7 0.34 0.43 8 2 0.54 0.12
All types 234 171 15.73 10.48 108 65 7.26 3.98 160 49 10.75 3.00
*Crude annual incidence rate, per 100 000 person-years.
F, female; M, male.
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adenocarcinoma was associated with increased odds of male
gender irrespective of anatomical location or age (OR 2.6, 95%
CI 1.78 to 3.90). Increasing age showed an overall inverse
relationship with the odds of male gender excluding those
aged ,50 years; again this relationship persisted when
anatomical location and histological subtype were considered
in the same logistic regression model.
Characteristics of male predominance of upper gastrointestinal
adenocarcinoma
The rise in incidence with increasing age was much more
marked in the intestinal versus diffuse subtype (fig 3A,B). For
the diffuse histological subtype the crude and age-specific
incidence rates were similar for males and females. Curve
fitting of the age-specific incidence data for diffuse subtypes
resulted in similar equations: y = 0.016 6 mean age2.007,
R2 = 0.999 and y = 0.016 6 mean age1.954, R2 = 0.989, for male
and females, respectively. The age at which the age-specific
incidence curve rose above zero was similar in males (33.0 years)
and females (35.8 years). For the intestinal histological subtype,
the age-specific incidence data were different for males and
females. Curve fitting indicated a similar incidence rate in males
(y = 0.0166mean age2.315, R2 = 0.990) and in females (y = 0.016
6mean age2.316, R2 = 0.998). However, the age-specific incidence
curve for females did not appear to deviate from zero until an
older age compared with male intestinal subtype. The age at
which the age-specific incidence curve rose above zero was
28.8 years in males versus 46.1 years in females indicates a delay
of 17.3 years in the appearance of intestinal subtype cancer in
females.
Characteristics of male predominance in other cancers
Analysis of all recorded cases of oesophageal adenocarcinoma in
the Scottish Cancer Registry between 1998 and 2002 produced
similar age-specific incidence curves to that observed in our
random sample of oesophageal adenorcarcinoma with an age
delay in the appearance of intestinal subtype cancer in females
of 15.6 years (table 5). Analysis of age-specific incidence curves
of squamous cell carcinoma of oesophagus, lung cancer (three
common histological types), bladder cancer (two common
histological types), colon cancer (all histologies) and pancreatic
cancer (all histologies) showed no evidence of a gender-related
delay in the incidence of these cancers. This analysis included
squamous cell carcinoma of lung and transitional cell carcinoma
of bladder, which have an M/F ratio of 2.1 and 2.6, respectively.
In the latter cancers, the higher male incidence was due to a
higher rate of increase rate rather than any gender specific delay
in the rise of incidence (table 5).
DISCUSSION
This study confirms the long-recognised male predominance of
adenocarcinoma of the upper gastrointestinal tract, the crude
incidence rates being 29.44 in males and 14.21 in females. It also
confirms that the degree of male predominance varies by
anatomical site of the adenocarcinoma, being greatest in the
oesophagus (M/F ratio = 3.50), less at the cardia (M/F
ratio = 2.00), and least in the more distal non-cardia region of
the stomach (M/F ratio = 1.65). This relationship between
anatomical site and male predominance has been observed in
several previous studies from different regions of the world.8 18
The proportion of the intestinal to diffuse histological
subtypes varied with anatomical locations, being 9.6:1 in the
oesophagus, 3.2:1 at the cardia and 1.9:1 in the distal stomach
(table 1). A high ratio of the intestinal/diffuse histological
subtypes has been reported in the cardia and non-cardia region
of the stomach in previous studies.4 19–22
A strong association was observed between male predomi-
nance and histological subtype. Regardless of anatomical
subtype, the crude incidence rate of intestinal type upper
gastrointestinal tract adenocarcinoma was higher in males, with
an M/F ratio of 2.65:1. In contrast, the crude incidence rates of
Figure 1 Age specific incidence rates of upper gastrointestinal
adenocarcinoma by gender. (A) combined intestinal and diffuse
subtypes; (B) intestinal subtype; and (C) diffuse subtype.
Upper gastrointestinal cancer
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the diffuse subtype were similar in male and female, with an M/
F ratio of 1.07:1.
Applying multivariable analysis to our population-based data
allowed us to investigate for the first time whether the gender
phenomenon was related to the anatomical site of upper
gastrointestinal cancer or to the histological subtype. This
indicated that it was the intestinal subtype that was associated
with male predominance rather than anatomical location. The
higher male predominance in oesophageal versus gastric
adenocarcinoma is explained by the higher incidence of
intestinal subtype in the former.
The Lauren histological classification was originally devised
to classify gastric adenocarcinoma and has proved to be of
aetiopathogenic value.1 The intestinal histological subtype of
gastric cancer develops against a background of chronic H pylori-
induced gastritis.2 23 The chronic inflammation causes atrophy
of specialised gastric glands that are replaced by intestinal
metaplasia from which the intestinal type of gastric adenocar-
cinoma is believed to originate. Oesophageal adenocarcinoma is
nearly always intestinal in subtype and histologically indis-
tinguishable from the intestinal subtype of adenocarcinoma of
the stomach. Oesophageal adenocarcinoma also resembles
intestinal subtype gastric cancer in its pathogenesis in that it
develops against a background of chronic mucosal damage.
Exposure of the squamous epithelium of the distal oesophagus
to refluxing gastric juice causes it to undergo metaplasia to
columnar type epithelium resembling the stomach and then to
the intestinal type of epithelium,24 25 from which the oesopha-
geal adenocarcinoma of intestinal phenotype develops. The
finding in our current study, that the intestinal type of
adenocarcinoma of the oesophagus and stomach show the
same male predominance, provides further evidence of similar-
ity of pathogenesis and supports applying the Lauren classifica-
tion to oesophageal cancers.
We further investigated the male predominance of intestinal
type upper gastrointestinal adenocarcinoma by comparing the
age-specific incidence rates of the two sexes. Curve fitting
indicated that the male and female were described by similar
power terms in the functions describing the curves. The only
difference between the curves was that the rise in the incidence
of female cancer lagged behind that of the male by 17.3 years.
The male predominance of this cancer is due to the rise of cancer
incidence with age in males commencing at 28.8 years of age
compared to 46.1 years of age for females. Sipponen and Correa
have previously reported a delay in the development of the
intestinal subtype of gastric cancer in females in the Finnish
population.26 A delay in development of oesophageal carcinoma
in females has not been reported previously but there are reports
of a delay in development of Barrett’s oesophagus in females
versus males.27 28
The fact that the rise in age-specific incidence is occurring
17.3 years later in females than males, but has the same slope,
indicates that there is temporary delay in development of the
cancer in females which then disappears around age 46. If the
protection against the development of cancer persisted
throughout life the power term in the function describing
the incidence rate would be expected to be different in females
compared with males. The maximum difference in the gender
incidence ratio will occur at whatever age the process
differentially influencing the carcinogenic process in males
versus females disappears. The difference in M/F ratio
increased to a maximum at 50–59 years of age (7.9:1) and
then showed a marked progressive decrease (fig 2). This
indicates the difference in the age-specific incidence of cancer
between males and females is limited to ,55 years of age.
Table 2 Distribution of upper gastrointestinal adenocarcinoma in different age groups by sex and histological subtypes
Histology
Age group
,50 50–59 60–69 70–79 >80 All ages
n Rate* n Rate* n Rate* n Rate* n Rate* n Rate{
Intestinal subtype Male 20 2.51 60 32.56 94 65.38 124 134.74 57 177.11 355 23.86
Female 6 0.57 8 4.14 21 12.50 52 38.94 60 77.44 147 9.00
Total 26 68 115 176 117 502
M/F 3.41 7.86 5.23 3.46 2.29 2.65
Diffuse subtype Male 7 0.68 14 7.56 25 17.38 27 29.34 10 31.07 83 5.58
Female 8 0.75 11 5.69 17 10.11 24 17.98 25 32.26 85 5.20
Total 15 25 42 51 35 168
M/F 0.89 1.33 1.72 1.63 0.96 1.07
Both subtypes Male 27 2.60 74 40.16 119 82.77 151 164.07 67 208.18 438 29.44
Female 14 1.32 19 9.83 38 22.62 76 56.93 85 109.71 232 14.21
Total 41 93 157 227 152 670
M/F 1.97 4.09 3.66 2.90 1.90 2.07
*Age-specific incidence rate per 100 000 person-years.
{Crude incidence rate per 100 000 person-years.
Figure 2 Male-to-female ratios of age-specific incidence rate of upper
gastrointestinal adenocarcinoma by histological subtype. Note that the
ratio of the intestinal subtype increases to a maximum at age group
50–59 years followed by a progressive decrease. F, female; M, male.
Upper gastrointestinal cancer
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In contrast to intestinal type adenocarcinoma, the diffuse
subtype showed no difference in age-specific incidence between
males and females. In addition, the power term in the function
describing the incidence rate for diffuse subtype was lower than
that for the intestinal subtype. This is consistent with a
stronger genetic predisposition being involved in the develop-
ment of the diffuse subtype of cancer and thus fewer mutations
are required to complete the carcinogenic process.29
Applying similar curve-fitting analysis to a range of other
types of cancers in the same population over the same time
period revealed no evidence of a gender-based delay phenom-
enon. In particular, cancers such as squamous carcinoma of lung
and transitional cell carcinoma of bladder which have a strong
male predominance related to smoking30 31 showed differences in
power term in the function describing the incidence rate
between the genders but no evidence of a delay in onset.
In summary, our study indicates (1) that the male pre-
dominance of gastrointestinal adenocarcinoma is related to the
intestinal subtype and is independent of whether the cancer
arises in the oesophagus or proximal or distal stomach; (2) that
the male predominance of the intestinal subtype is due to a
delay of 17.3 years in its rise in incidence in females; and (3) that
this delay is due to differences between males and females of
less than 55 years of age.
The reason for the difference in the development of the
intestinal subtype of upper gastrointestinal cancer in females
versus males is unclear and deserves further consideration and
investigation. The fact that the delay is occurring at age less
than 55 years makes it likely to be related to an endogenous
protective effect associated with the reproductive years in the
female. Fox et al reported gender specific H pylori-related
carcinogenesis in insulin gastrin transgenic (INS-GAS) mice
Table 3 Distribution of upper gastrointestinal adenocarcinoma in different age groups by gender and tumour location
Tumour location
Age group
,50 50–59 60–69 70–79 >80 All ages
n Rate* n Rate* n Rate* n Rate* n Rate* n Rate{
Gastric non-cardia Male 9 0.86 28 15.20 54 37.56 69 74.97 48 149.15 208 13.98
Female 11 1.04 10 5.17 25 14.88 41 30.71 51 65.73 138 8.46
Total 20 38 79 110 99 346
M/F 0.83 2.94 2.52 2.44 2.27 1.65
Gastric cardia Male 9 0.86 15 8.14 24 16.69 36 39.12 9 27.97 93 6.25
Female 2 0.18 5 2.59 5 2.98 18 13.48 21 27.11 51 3.12
Total 11 20 29 54 30 144
M/F 4.78 3.14 5.69 2.90 1.03 2.00
Distal oesophagus Male 9 0.86 31 16.82 41 28.52 46 49.98 10 31.07 137 9.21
Female 1 0.09 4 2.07 8 4.76 17 12.73 13 16.78 43 2.63
Total 10 35 49 63 23 180
M/F 9.56 8.13 5.99 3.93 1.85 3.50
All sites Male 27 2.60 74 40.16 119 82.77 151 164.07 67 208.18 438 29.44
Female 14 1.32 19 9.83 38 22.62 76 56.93 85 109.71 232 14.21
Total 41 93 157 227 152 670
M/F 1.97 4.09 3.66 2.90 1.90 2.07
*Age-specific incidence rate per 100 000 person-years.
{Crude incidence rate per 100 000 person-years.
F, female; M, male.
Table 4 Logistic regression analysis of association between gender (in favour of male) and histological subtype, tumour location and age
Independent variable considered individually Multivariable model
p Value OR (95% CI for OR) p Value OR (95% CI for OR)
Histological subtype
Diffuse (referent) 1.000 1.000
Intestinal 0.00 2.473 (1.728 to 3.539) 0.00 2.637 (1.784 to 3.896)
Tumour site
Gastric non-cardia (referent) 1.000 1.000
Gastric cardia 0.36 1.210 (0.808 to 1.811) 0.98 0.995 (0.648 to 1.529)
Distal oesophagus 0.00 2.114 (1.410 to 3.168) 0.16 1.368 (0.883 to 2.121)
p Value for overall effect 0.00 0.33
Age band (years)
,50 (referent) 1.000 1.000
50–59 0.09 2.019 (0.890 to 4.581) 0.17 1.821 (0.782 to 4.240)
60–69 0.20 1.624 (0.773 to 3.409) 0.33 1.466 (0.681 to 3.155)
70–79 0.93 1.030 (0.511 to 2.079) 0.72 0.876 (0.423 to 1.813)
>80 0.02 0.409 (0.199 to 0.840) 0.01 0.347 (0.164 to 0.736)
p Value for overall effect 0.000 0.000
CI, confidence interval; OR, odds ratio.
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which was explained by a protective effect of 17b-oestradiol.32–34
In humans, delayed menopause and hormone replacement
therapy may protect against gastric cancer.35–37 The intestinal
subtype of cancer arises against a background of chronic
inflammation and tissue damage. The female sex hormone,
oestrogen, is known to suppress the inflammatory response and
cytokine production in certain tissues and might be exerting
similar effects in the upper GI tract.38 39 In addition, females
have lower body iron stores during their reproductive years and
this might modify the degree of DNA damage arising from
chronic inflammation.40–43
Several observations indicate that the delayed development in
females is unlikely to be explained by different lifestyle factors,
such as smoking. First, in cancers with male predominance due
to exogenous lifestyle factors (ie, lung, bladder), the age specific
incidence data demonstrate differences in the power terms for
the function describing the data rather than a delay in
appearance of the cancer. Second, recent studies have reported
male predominance of gastric cancer in never-smokers.44 45
Third, male predominance is observed in animal models of
gastric cancer raised in an identical environment.46 Fourth,
smoking rates in the United Kingdom available from 1978 to
1998 are similar for males and females under 50 years of age.47
The intestinal subtype of gastric adenocarcinoma arises due
to progression of chronic superficial gastritis to atrophic gastritis
to intestinal metaplasia to dysplasia and finally cancer.2 The
incidence of atrophic gastritis is the same in males and females
and some studies have suggested a higher incidence of intestinal
metaplasia and dysplasia in males.48–50 This suggests that the
gender phenomenon is acting at or after the metaplastic stage.
With respect to the oesophagus, columnar epithelial metaplasia
is more common in males than females (M/F 1.7:1) and
specialised intestinal epithelial more markedly so (M/
F = 2.1:1). This again indicates the gender phenomenon is
evident at and after the metaplastic stage.51
In conclusion, this study indicates that the marked male
predominance of upper gastrointestinal adenocarcinoma is due
to a more than 17 years delay in the development of the
intestinal subtype of the cancer. The basis of this phenomenon
requires investigation as it accounts for a substantial proportion
of upper GI cancers and of such cancers occurring at a younger
age when the personal, social and economical implications are
greatest. It is likely also to give valuable new insights into the
control of the carcinogenic process.
Figure 3 (A) Modelling of age-specific incidence rate curve of intestinal
subtype upper gastrointestinal (GI) adenocarcinoma by gender. This shows
similar slope of curves but delayed rise in curve in female. (B) Modelling of
age-specific incidence rate curve of diffuse subtype upper GI
adenocarcinoma by gender. This shows similar slope of curves and also
similar age of rise in age-specific incidence rate in males and females.
Table 5 Parameters from the fit of the equation I(t) = a6(t2d)b to age-specific incidence rates of upper gastrointestinal adenocarcinomas compared
with other cancers from the West of Scotland 1998–2002
M/F ratio
Male Female Gender bias
(of crude
incidence) a b d a b d Da Db Dd
Upper GI adenocarcinoma, intestinal
subtype
2.65 0.02 2.32 28.8 0.02 2.32 46.1 0.0 0.0 17.3
Upper GI adenocarcinoma, diffuse
subtype
1.07 0.02 2.01 33.0 0.01 1.95 35.8 0.0 20.1 2.8
Oesophageal adenocarcinoma 2.96 0.02 2.21 33.1 0.01 2.09 48.7 0.0 20.1 15.6
Oesophageal squamous cell
carcinoma
1.07 0.02 2.16 34.7 0.01 2.15 37.0 20.1 20.1 2.3
Squamous cell carcinoma of lung 2.10 0.02 2.64 38.2 0.02 2.47 38.7 0.0 20.2 0.5
Adenocarcinoma of lung 1.32 0.03 2.24 34.5 0.02 2.18 32.5 0.0 20.1 22.0
Small cell carcinoma of lung 1.14 0.02 2.38 34.4 0.04 2.16 37.3 0.0 20.2 2.9
Squamous cell carcinoma of bladder 0.88 0.001 2.22 38.2 0.001 2.31 38.8 0.0 0.1 0.6
Transitional cell carcinoma of bladder 2.57 0.01 2.63 40.0 0.01 2.20 36.0 0.0 20.4 24.0
Cancer of the colon 1.06 0.02 2.49 34.8 0.06 2.21 36.7 0.0 20.1 1.9
Cancer of the pancreas 1.07 0.09 1.84 39.4 0.04 1.90 36.2 20.1 0.1 23.2
In the equation, I is the incidence rate of cancer at age t, which is the mean age of the age group; a is a scaling factor, b is a power term that reflect the rate of increasing incidence
with age, and d is a delay term for the time between birth and age of rise of age-specific incidence curve above zero.
F, female; GI, gastrointestinal; M, male.
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